About the journal
Immunity is a journal published by Cell Press in United States. It is listed in MEDLINE and PUBMED according to the sources read. Declared publication charge: 9,080 USD. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Cell Press
- ISSN
- 1097-4180 · 1074-7613
- Country
- United States
- Access
- Not open access / not declared
- Declared publication charge
- 9,080 USD
Index listings
- MEDLINE · 1994-01-01
- PUBMED · 2008-07-18
- Indexing
- MEDLINE · PUBMED
- APC
- 9,080 USD
- Declared review time (DOAJ)
- —
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
6795
Last recorded publication year
2026
h-index
565
i10-index
5429
From OpenAlex open data (CC0).
Editorial & policy4
- Observed digital preservation (Keepers registry)— snapshot 2026-09-21
- CLOCKSSPortico
- Norwegian register (HK-dir)— 2027
- Level 2 — top tier (~20% of the field's channels)
- Open references deposited at Crossref
- 96%
- ORCID iDs in current deposits
- 70%
- Deposits licence metadata at Crossref
- ✓
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 9432918
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- Immune Cell Function and Interaction
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
- Immunotherapy and Immune Responses
- Immune Response and Inflammation
- Immune Response and Inflammation
Show all subjects (50)
- IL-33, ST2, and ILC Pathways
- Immune cells in cancer
- IL-33, ST2, and ILC Pathways
- Immune cells in cancer
- interferon and immune responses
- interferon and immune responses
- CAR-T cell therapy research
- CAR-T cell therapy research
- Monoclonal and Polyclonal Antibodies Research
- Monoclonal and Polyclonal Antibodies Research
- Inflammasome and immune disorders
- Inflammasome and immune disorders
- Cytokine Signaling Pathways and Interactions
- Cytokine Signaling Pathways and Interactions
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- Neuroinflammation and Neurodegeneration Mechanisms
- Neuroinflammation and Neurodegeneration Mechanisms
- NF-κB Signaling Pathways
- NF-κB Signaling Pathways
- Cell Adhesion Molecules Research
- Cell Adhesion Molecules Research
- HIV Research and Treatment
- HIV Research and Treatment
- Diabetes and associated disorders
- Diabetes and associated disorders
- Phagocytosis and Immune Regulation
- Phagocytosis and Immune Regulation
- Gut microbiota and health
- Gut microbiota and health
- Immunodeficiency and Autoimmune Disorders
- Cytomegalovirus and herpesvirus research
- Cytomegalovirus and herpesvirus research
- Immunodeficiency and Autoimmune Disorders
- Immune responses and vaccinations
- Eosinophilic Esophagitis
- Eosinophilic Esophagitis
- Immune responses and vaccinations
- vaccines and immunoinformatics approaches
- vaccines and immunoinformatics approaches
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ